Statistics for 72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon α-2a plus adefovir vs. peginterferon α-2a plus placebo vs. adefovir in chronic delta hepatitis

Total visits

views
72 week data of the HIDIT-1 trial: A multicenter randomised study comparing peginterferon α-2a plus adefovir vs. peginterferon α-2a plus placebo vs. adefovir in chronic delta hepatitis 3

Total visits per month

views
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 3